Long Term Safety Assessment of SER120 in Patients With Nocturia
NCT00981682 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 376
Last updated 2021-01-20
Summary
The hypothesis of this study is that SER120 is safe and well tolerated for use in nocturic patients.
Conditions
- Nocturia
Interventions
- DRUG
-
SER120
once a day treatment of nocturia
Sponsors & Collaborators
-
Serenity Pharmaceuticals, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-08-31
Countries
- United States
Study Locations
More Related Trials
-
An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
NCT00615836 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
NCT00477490 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis
NCT02553798 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients
NCT01223937 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3
-
Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing
NCT01819168 ·Status: COMPLETED
-
Duloxetine in the Treatment of Stress Urinary Incontinence.
NCT00191087 ·Status: COMPLETED ·Phase: PHASE3
-
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
NCT01684800 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Phase III Duloxetine Study for Stress Urinary Incontinence
NCT00191204 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder
NCT00928070 ·Status: COMPLETED ·Phase: PHASE4
-
Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary
NCT01552343 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men
NCT01694498 ·Status: COMPLETED ·Phase: PHASE2
-
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
NCT01729819 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
NCT04090190 ·Status: COMPLETED ·Phase: PHASE4
-
A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder
NCT02045862 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
NCT02262936 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
NCT00688688 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet
NCT00139724 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
NCT03201419 ·Status: COMPLETED ·Phase: PHASE2
-
Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
NCT01876186 ·Status: UNKNOWN ·Phase: PHASE4
-
To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence
NCT00190632 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.
NCT00190814 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Glycopyrronium in Axillary Hyperhydrosis
NCT02530281 ·Status: COMPLETED ·Phase: PHASE3